These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23039668)

  • 1. Mapping of distributions of a local b-matrix cross-term strength using diffusion tensor MRI in patients with Alzheimer's disease.
    Jahng GH; Xu S; Kim MJ
    Med Phys; 2012 Oct; 39(10):6324-31. PubMed ID: 23039668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local susceptibility causes diffusion alterations in patients with Alzheimer's disease and mild cognitive impairment.
    Jahng GH; Xu S
    Brain Imaging Behav; 2012 Sep; 6(3):426-36. PubMed ID: 22415193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DTI studies in patients with Alzheimer's disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients.
    Jahng GH; Xu S; Weiner MW; Meyerhoff DJ; Park S; Schuff N
    Neuroradiology; 2011 Oct; 53(10):749-62. PubMed ID: 21340578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment.
    Hwang EJ; Kim HG; Kim D; Rhee HY; Ryu CW; Liu T; Wang Y; Jahng GH
    Med Phys; 2016 Aug; 43(8):4718. PubMed ID: 27487889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment.
    Gao L; Jiang Z; Cai Z; Cai M; Zhang Q; Ma Y; Li G; Zhao F; Ma Q
    Mol Med Rep; 2017 Dec; 16(6):8209-8215. PubMed ID: 28990041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease.
    Seo EH; Lee DY; Lee JM; Park JS; Sohn BK; Lee DS; Choe YM; Woo JI
    PLoS One; 2013; 8(1):e53922. PubMed ID: 23335980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer's Disease or Mild Cognitive Impairment.
    Chen Y; Yan H; Han Z; Bi Y; Chen H; Liu J; Wu M; Wang Y; Zhang Y
    Curr Alzheimer Res; 2016; 13(3):234-42. PubMed ID: 26906355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients.
    Scrascia F; Curcio G; Ursini F; Trotta L; Quintiliani L; Migliore S; Altamura C; Pitocco F; Altavilla R; Melgari JM; Quattrocchi CC; Vernieri F
    J Alzheimers Dis; 2014; 38(4):939-50. PubMed ID: 24121958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
    Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
    Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
    Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
    Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
    J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques.
    Stahl R; Dietrich O; Teipel SJ; Hampel H; Reiser MF; Schoenberg SO
    Radiology; 2007 May; 243(2):483-92. PubMed ID: 17456872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Functional Connectivity Architecture in Alzheimer's Disease and Mild Cognitive Impairment: A Whole-Brain, Data-Driven Analysis.
    Zhou B; Yao H; Wang P; Zhang Z; Zhan Y; Ma J; Xu K; Wang L; An N; Liu Y; Zhang X
    Biomed Res Int; 2015; 2015():495375. PubMed ID: 26167487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles.
    Park MH; Han C
    Int Psychogeriatr; 2015 Mar; 27(3):429-37. PubMed ID: 25255915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
    Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
    J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
    Liu Y; Li N; Zhou L; Li Q; Li W
    Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.